Ihor Vynnychenko
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.2%
- Molecular Biology top 5%
- Otorhinolaryngology top 0.1%
- Surgery top 2%
- Co-authors
- Ricard Mesı́aDidier CupissolCarsten BokemeyerFrédéric PeyradeFernando RiveraNadia AmellalJan B. VermorkenÉva Remenár
- Topics
- Lung Cancer Treatments and Mutations (18 papers)Cancer Immunotherapy and Biomarkers (14 papers)Gastric Cancer Management and Outcomes (13 papers)
- Partner nations
- UkraineUnited StatesGermany
In The Last Decade
Ihor Vynnychenko
55 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 4.6k
- Pulmonary and Respiratory Medicine 4.3k
- Molecular Biology 1.4k
- Otorhinolaryngology 1.4k
- Surgery 1.4k
Countries citing papers authored by Ihor Vynnychenko
This map shows the geographic impact of Ihor Vynnychenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ihor Vynnychenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ihor Vynnychenko more than expected).
Fields of papers citing papers by Ihor Vynnychenko
This network shows the impact of papers produced by Ihor Vynnychenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ihor Vynnychenko. The network helps show where Ihor Vynnychenko may publish in the future.
Co-authorship network of co-authors of Ihor Vynnychenko
This figure shows the co-authorship network connecting the top 25 collaborators of Ihor Vynnychenko. A scholar is included among the top collaborators of Ihor Vynnychenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ihor Vynnychenko. Ihor Vynnychenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 5 | |
| 3 | 12 | |
| 4 | 10 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 6 | |
| 8 | Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trialbreakdown → | 405 |
| 9 | 15 | |
| 10 | 5 | |
| 11 | 18 | |
| 12 | 2 | |
| 13 | 15 | |
| 14 | 14 | |
| 15 | 13 | |
| 16 | 5 | |
| 17 | Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trialbreakdown → | 425 |
| 18 | 88 | |
| 19 | Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trialbreakdown → | 1046 |
| 20 | Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancerbreakdown → | 2594 |
About Ihor Vynnychenko
Ihor Vynnychenko is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 57 papers that have together received 7.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Gastric Cancer Management and Outcomes (13 papers). The work is most often cited by research in Otorhinolaryngology (1.4k citations), Oncology (4.6k citations) and Pulmonary and Respiratory Medicine (4.3k citations). Ihor Vynnychenko has collaborated with scholars based in Ukraine, United States and Germany. Frequent co-authors include Ricard Mesı́a, Didier Cupissol, Carsten Bokemeyer, Frédéric Peyrade, Fernando Rivera, Nadia Amellal, Jan B. Vermorken, Éva Remenár, Armin Schueler and Andrzej Kawecki. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.